Original Articles

Subclinical leprosy detection in contact person of multibacillary leprosy patients

Made Wardana , Made Swastika, luh Mas Rusyanti

Made Wardana
Dermatology and Genital Department, Faculty of Medicine, Udayana University, Bali - Indonesia. Email: wardana123@yahoo.com

Made Swastika
Dermatology and Genital Department, Faculty of Medicine, Udayana University, Bali - Indonesia

luh Mas Rusyanti
Dermatology and Genital Department, Faculty of Medicine, Udayana University, Bali - Indonesia
Online First: December 15, 2016 | Cite this Article
Wardana, M., Swastika, M., Rusyanti, l. 2016. Subclinical leprosy detection in contact person of multibacillary leprosy patients. Indonesia Journal of Biomedical Science 10(2): 10-14. DOI:10.15562/ijbs.v10i2.123

Background: Leprosy is a chronic infectious disease caused by Mycobacterium leprae and generally manifest as neurodegenerative disorder which may lead to permanent disability. Whether its prevalence tend to be decreased, new and relaps case, complication such as skin reaction, and disability remain problematic whether in much smaller magnitude. Objective: In this study, we observe the prevalence of subclinical leprosy in population who live with leprosy patients in order to determine the rate of transmission and initiate early treatment for those with subclinical disease as well as providing data for future research. Methods: A cross-sectional study was conducted in dermatology and genital clinic of Sanglah General Hospital from may 2016 to August 2016 which included all patient’ family that agreed to be enrolled. The leprosy status of the sample was evaluated using lateral flow test that detect IgM anti-PGL-1 in the serum. Results: 28 leprosy patients and 73 contact person were enrolled in this study. Among the patients, 21 (75%) were Balinese and 7 (25%) were Javanese. Lateral Flow examination found that almost all results were positive (27; 96.42%) for the patients with just 1 patient showed negative result. Meanwhile, from 73 contact person, 11 appear to be positive (15.06%). Conclusion: lateral flow test was proved to be effective method of detecting M. leprae infection and we found 15.06% of contact person had subclinical leprosy.


Rea TH. Leprosy In: Freedberg IM, Eisen AZ, Wolf K, Austen KF, Goldsmith IA, Katz SI. Eds. Fitzpatrick’s Dermatology in General medicine, 8th Ed. New York:McGraw-Hill, 2012, p.1962-1971.

James WD, Berger TG, Elston DM. Hansesn’s Disease (Leprosy) In: James WD, Berger TG, Elston DM. Eds. Andrew’s Disease of the Skin Clinical Dermatology, 10th Ed. London: Elseviers, 2006, p.343-352.

World Health Organization. 2015. Global Leprosy Update 2014: Need for Early Case Detection. WHO Weekly Epidemiological Record; 36(90): 461-76.

Departemen Kesehatan R.I. Direktorat Jendral Pengendalian Penyakit dan Penyehatan Lingkungan 2005, Buku Pedoman Nasional Pemberantasan penyakit kusta.

Dinas Kesehatan Propinsi Bali. 2015. Profil Kesehatan Propinsi Bali. Available online: www.depkes.go.id/PROPINSI_2015/17_Profil_Kes.Prov.Bali_2015.pdf (Accessed 2/12/2016).

Bakker MI, Hatta M, Kwenang A, Faber WR, van Beer SM, Klatser PR, Oskam L. Population Survey to Determine Risk Factors for Mycobacterium leprae Transmission and Infection. Intl J Epidemiology 2004; 33:1-8. DOI:10.1093/ije/dyh266.

Izumi S. Subclinical Infection by Mycobacterium leprae. Int J Lepr Other Mycobact Dis Dec 1999. Available online: http//www.findarticles.com. Accessed 4/22/2005.

Pattyn SR, Ursi D, Leven M, Grillone S, Raes V. Detection of Mycobacterium leprae in Nasal Swabs of Leprosy Patients and Their Contacts. Int. J. Lepr. 1993;61(3):389-393.

Amirudin MD, Hakim Z, Darwis E (2003) Diagnosis Penyakit Kusta in: Sjamsoe-Daili ES, Menaldi SL, Ismiarto SP, Nilasari H Eds. Kusta, 2nd ed. Jakarta: Balai Penerbit Fakultas Kedokteran Universitas Indonesia, p.12-32

Buchanan TM. Serology of leprosy in: Hastings RC, Ed. Leprosy, 2nd Ed. Singapore: Churchill Livingstone 1994, p.169-176.

Rees RJW, Young DB. The microbiology of leprosy In: Hastings RC, Ed. Leprosy, 2nd Ed. Singapore:Churchill Livingstone 1994, p.49-83.

Draper P. Stucture of Mycobacterium Leprae. Lepr Rev. 1986;57 (suppl. 2):15-20.

Buhrer-Sekula S, Smith HL Gussenhoven GC van Leeuwen J, Amador S, Fujiwara T, Klatser PR, Oskam L. Simple and Fast Lateral Flow Test for Classification of Leprosy Patients and Identification of Contacts with High risk of Developing Leprosy. J Clin Microbiol 2003;41(5):1991-1995.

Buhrer-Sekula S, Visschedijk J, grossi MAF, Dhakal KP. The ML Flow Test as A Point of care test for Leporsy Programme for Leprosy Patients. Lepr Rev 2007;78(1):70-9.

Buhrer-Sekula S, Sarno EN, Oskam L, Koop S, Wichers I, Nery JAC, Viera LM, De Matos HJ, Faber WR, Klatser PR. Use of ML Dipstick as a Tool to Classify Leprosy Patients. Int J Lepr Other Mycobact Dis 2000; 68:456-462.

Pfaltzgraff RE, Ramu G. Clinical leprosy. In: Hasting RC Ed. Leprosy,2nd Ed. London: Churchill Livingstone, 1994, p.237-290.

No Supplementary Material available for this article.
Article Views      : 216
PDF Downloads : 37